Experts in dermatology comment on the patient considerations required when deciding on systemic treatment for basal cell carcinoma.
As your youngest patients begin the return to the classroom, pediatric dermatologist Latanya Benjamin, MD, FAAD, FAAP, offers perspectives in education and skin care tips.
Investigators also developed a MELASQoL model using 4 predictors of quality of life impacts in patients with melasma.
In ethnic and racial minority populations, more than 12,000 standard skin cancer screenings would be done to identify 1 case of melanoma, according to a recent study.
In a recent study, authors argue that psychosocial impacts should be at the forefront of the discussion in acne scarring, noting that psychopharmacological management may be necessary in instances of severe psychiatric comorbidities.
Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Bhatia also shared insights into ritlecitinib for alopecia areata at Fall Clinical 2023.
Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.
Understanding the underlying motivation for seeking out minimally invasive cosmetic procedures is important to provide individualized and holistic care to patients.
A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.
This year’s virtual atopic dermatitis conference takes place on Sunday, December 10, 2023.
Saranya Wyles, MD, PhD, offers guidance on integrating advanced skincare technologies into their practices and the importance of staying updated through events like the Science of Skincare summit.
In honor of National Healthy Skin Month, it is the perfect time to encourage patients to integrate gentle laser treatments into their yearly routine to maintain healthy, radiant skin.
Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Shah is presenting alongside a panel of leading experts at Fall Clinical 2023.
Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
She shares her top 5 considerations for all dermatology drug prescribers.
Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Investigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.
2 Clarke Drive Cranbury, NJ 08512